Literature DB >> 33469221

Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.

Jingyun Yang1, Wei Wang1, Zimin Chen1, Shuaiyao Lu2, Fanli Yang1, Zhenfei Bi1, Linlin Bao3, Fei Mo1, Xue Li1, Yong Huang1, Weiqi Hong1, Yun Yang2, Yuan Zhao2, Fei Ye1, Sheng Lin1, Wei Deng3, Hua Chen1, Hong Lei1, Ziqi Zhang1, Min Luo1, Hong Gao3, Yue Zheng1, Yanqiu Gong1, Xiaohua Jiang1, Yanfeng Xu3, Qi Lv3, Dan Li1, Manni Wang1, Fengdi Li3, Shunyi Wang3, Guanpeng Wang3, Pin Yu3, Yajin Qu3, Li Yang1, Hongxin Deng1, Aiping Tong1, Jiong Li1, Zhenling Wang1, Jinliang Yang1, Guobo Shen1, Zhiwei Zhao1, Yuhua Li4, Jingwen Luo1, Hongqi Liu2, Wenhai Yu2, Mengli Yang2, Jingwen Xu2, Junbin Wang2, Haiyan Li2, Haixuan Wang2, Dexuan Kuang2, Panpan Lin1, Zhengtao Hu5, Wei Guo5, Wei Cheng1, Yanlin He5, Xiangrong Song1, Chong Chen1, Zhihong Xue1, Shaohua Yao1, Lu Chen1, Xuelei Ma1, Siyuan Chen1, Maling Gou1, Weijin Huang4, Youchun Wang4, Changfa Fan4, Zhixin Tian6, Ming Shi7, Fu-Sheng Wang7, Lunzhi Dai1, Min Wu1, Gen Li8, Guangyu Wang9, Yong Peng1, Zhiyong Qian1, Canhua Huang1, Johnson Yiu-Nam Lau10, Zhenglin Yang11, Yuquan Wei1, Xiaobo Cen1,5, Xiaozhong Peng2,12, Chuan Qin3, Kang Zhang13, Guangwen Lu14,15, Xiawei Wei16.   

Abstract

Entities:  

Year:  2021        PMID: 33469221     DOI: 10.1038/s41586-020-03108-4

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.

Authors:  Jira Chansaenroj; Ritthideach Yorsaeng; Jiratchaya Puenpa; Nasamon Wanlapakorn; Chintana Chirathaworn; Natthinee Sudhinaraset; Manit Sripramote; Piti Chalongviriyalert; Supunee Jirajariyavej; Phatharaporn Kiatpanabhikul; Jatuporn Saiyarin; Chulikorn Soudon; Orawan Thienfaidee; Thitisan Palakawong Na Ayuthaya; Chantapat Brukesawan; Duangnapa Intharasongkroh; Dootchai Chaiwanichsiri; Mila Issarasongkhram; Rungrueng Kitphati; Anek Mungaomklang; Arunee Thitithanyanont; Pijaya Nagavajara; Yong Poovorawan
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.240

2.  A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.

Authors:  Fengxia Gao; Jingjing Huang; Tingting Li; Chao Hu; Meiying Shen; Song Mu; Feiyang Luo; Shuyi Song; Yanan Hao; Wang Wang; Xiaojian Han; Chen Qian; Yingming Wang; Ruixin Wu; Luo Li; Shenglong Li; Aishun Jin
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.